BRD5814

BRD5814 is a D2R antagonist. BRD5814 can be used in schizophrenia research[1].

Product Specifications

CAS Number

1953181-29-7

UNSPSC

12352005

Target

Dopamine Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/brd5814.html

Smiles

FC(C1=CC=CC=C1OCCN2CCC(C)(OC3=CC=C(Cl)C=C3)CC2)(F)F

Molecular Formula

C21H23ClF3NO2

Molecular Weight

413.86

References & Citations

[1]Weïwer M, et al. Functionally Biased D2R Antagonists: Targeting the β-Arrestin Pathway to Improve Antipsychotic Treatment. ACS Chem Biol. 2018 Apr 20;13 (4) :1038-1047.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Isoform

D2 Receptor

More Discoveries

Explore Other Products

Browse additional items from our catalog

16688061 1.0 µg DNA

COX5BP2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

View Details

201-12-3469 96 Tests

Human Cholinergic Receptor, Muscarinic 1 (CHRM1) ELISA Kit

View Details

sc-425552-ACT 20 µg

Myozenin 2 CRISPR Activation Plasmid (m)

View Details

GTR15284849 1 Vial

Lentiviral human PKD1 shRNA (UAS) - Lentiviral human PKD1 shRNA (UAS) (25)

View Details

MBS1250421 Inquire

Recombinant Cryptococcus neoformans var. neoformans serotype D tRNA-dihydrouridine (47) synthase [NAD (P) (+)], partial

View Details

TA805094 100 µL

p16INK4A (CDKN2A) Mouse Monoclonal Antibody [Clone ID: OTI12C2]

View Details